drugs

Serious side effects raise safety questions for new weight-loss drugs In recent years, glucagon-like peptide-1 receptor agonists (GLP-1), such as semaglutide and liraglutide (marketed respectively as Wegovy and Ozempic), have…

Revocation of the authorisation of obetycholic acid for the treatment of primary biliary cholangitis (CBP) The recent decision by the European Commission to withdraw marketing authorisation for obeticlic acid for the treatment of primary…

The pharmaceutical company Eli Lilly has launched single dose vials of Zepbound, a cheaper version of tirzepatide The battle against obesity has taken a significant step forward with the introduction of a new, cheaper version of…

New study presents a tool to determine the need for coronary angioplasty through AI The battle against obesity may have found a new ally. Amicretina, an experimental pill developed by Novo Nordisk, has shown promising results in a phase I…

An international study is testing a new drug that can preserve the function of pancreas beta cells Type 1 diabetes, an autoimmune disease that mainly affects children and adolescents, is a major challenge for the scientific community. The…

Increasing numbers of boys and girls are dealing with substance abuse, gambling and digital addictions Substance use and digital addiction among young people is an emergency that requires increasing attention. According to the latest data,…

The substance, which is abused for recreational purposes, could be a new hope against some mental disorders Ketamine, a synthetic substance discovered in the 1960s, has a complex and fascinating profile. Originally developed as an…

A new bill: physical activity in medical prescriptions A revolution for the health of Italians looms on the horizon. The Senate has unanimously approved a bill that could revolutionize the way we think about health and disease prevention.…

According to recent research, the weight loss drug Wegovy could be a powerful ally in the fight against smoking A surprising discovery could revolutionize the way we deal with tobacco addiction. According to recent research, the drug…

Lorlatinib, a new lung cancer drug. Recorded an 81% reduction in the risk of progression and death A breakthrough drug, lorlatinib, is proving to be a powerful weapon against lung cancer. In particular, it is revolutionizing the treatment…